Medlinker Funding: $842M Raised, Series E (2021)

Medlinker funding overview

Medlinker is based in Chengdu, China. Medlinker has raised $842M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in December 2021. The round record for Medlinker runs through 2021; nothing later has been disclosed. Investors on record include China Investment Corp (CIC), Sequoia Capital, China Renaissance, Tencent, FY Capital, Sino Biopharmaceutical. 6 distinct backers are named across the disclosed rounds.

Medlinker at a glance

Total raised: $842M
Latest round: Series E
Latest round date: December 2021
Headquarters: Chengdu, China
Notable investors: China Investment Corp (CIC), Sequoia Capital, China Renaissance, Tencent, FY Capital, Sino Biopharmaceutical

Frequently asked about Medlinker funding

How much has Medlinker raised?: Medlinker has raised $842M in total disclosed funding across the rounds on record.
Who has invested in Medlinker?: China Investment Corp (CIC), Sequoia Capital, China Renaissance, Tencent, FY Capital, Sino Biopharmaceutical are named among the investors backing Medlinker.
What was the latest Medlinker funding round?: The most recent disclosed round is a Series E, announced in December 2021.
Where is Medlinker based?: Medlinker is based in Chengdu, China.
When did Medlinker last raise?: The last disclosed Medlinker round closed in December 2021 at Series E.

Medlinker totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Chengdu below to benchmark round size and investor mix.

Medlinker Funding: $842M Raised, Series E (2021)

Medlinker funding overview

Medlinker at a glance

Frequently asked about Medlinker funding

Companies related to Medlinker (18)

Browse related funding lists (6)